Valuation Metrics and Recent Changes
As of 17 August 2026, Grauer & Weil trades at ₹68.00, up 1.61% from the previous close of ₹66.92. The stock’s 52-week range spans from ₹49.70 to ₹99.75, indicating a recovery from its lows but still well below its peak. The company’s P/E ratio currently stands at 19.24, a level that has pushed its valuation grade from fair to expensive. This is a significant development given the company’s historical valuation context and its standing among peers.
The price-to-book value ratio is at 2.85, further underscoring the premium investors are paying relative to the company’s net asset value. Other valuation multiples such as EV/EBITDA at 13.96 and EV/EBIT at 16.06 also reflect a stretched valuation, though these remain more moderate compared to some peers in the commodity chemicals space.
Peer Comparison Highlights
When compared with key competitors, Grauer & Weil’s valuation appears more reasonable but still expensive. For instance, Navin Fluorine International trades at a P/E of 53.19 and EV/EBITDA of 34.30, while Himadri Speciality Chemical commands a P/E of 49.5 and EV/EBITDA of 39.27. Other peers such as Sumitomo Chemical and Acutaas Chemicals exhibit even higher multiples, with P/E ratios exceeding 49 and EV/EBITDA multiples above 39 and 48 respectively.
On the other hand, companies like Atul and Aarti Industries maintain fair valuation grades with P/E ratios of 24.92 and 37.18 respectively, and EV/EBITDA multiples below 18. This positions Grauer & Weil in a middle ground—expensive relative to some but cheaper than the most richly valued peers.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Financial Performance and Returns Context
Grauer & Weil’s return profile over various time horizons presents a mixed picture. The stock has underperformed the Sensex over the short and medium term, with a one-month return of -13.27% versus the Sensex’s 1.24%, and a one-year return of -26.68% compared to the Sensex’s -3.21%. Year-to-date, the stock’s decline of -8.63% closely mirrors the Sensex’s -8.46% performance.
However, over longer periods, Grauer & Weil has delivered robust gains, with a five-year return of 113.30% significantly outpacing the Sensex’s 40.72%, and a ten-year return of 349.44% more than doubling the benchmark’s 177.10%. This long-term outperformance highlights the company’s underlying growth potential despite recent valuation pressures.
Quality and Efficiency Metrics
The company’s operational efficiency remains strong, with a return on capital employed (ROCE) of 26.41% and return on equity (ROE) of 15.16%. These figures indicate effective utilisation of capital and shareholder funds, supporting the premium valuation to some extent. However, the PEG ratio of 2.85 suggests that earnings growth expectations are not fully aligned with the current price, contributing to the expensive valuation grade.
Mojo Score and Grade Revision
Grauer & Weil’s Mojo Score currently stands at 34.0, reflecting a cautious stance on the stock’s fundamentals and valuation. The recent downgrade from Hold to Sell on 22 July 2026 signals increased risk perception among analysts, primarily driven by the stretched valuation parameters and subdued near-term price momentum.
Given the small-cap status of the company, investors should weigh the valuation premium against the inherent volatility and sector-specific risks in commodity chemicals. The stock’s modest day change of 1.61% on 17 August 2026 indicates some buying interest, but the broader trend remains under pressure.
Grauer & Weil (India) Ltd or something better? Our SwitchER feature analyzes this small-cap Commodity Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investment Implications
Investors considering Grauer & Weil must carefully assess the valuation premium in the context of the company’s growth prospects and sector dynamics. While the company’s strong ROCE and ROE metrics support its operational quality, the elevated P/E and P/BV ratios suggest limited margin of safety at current prices.
Comparatively, peers with very expensive valuations may offer higher growth but come with increased risk, whereas those with fair valuations might provide more balanced risk-reward profiles. The downgrade to a Sell rating by MarketsMOJO reflects this nuanced view, advising caution amid stretched multiples and recent underperformance.
Long-term investors who have held the stock through its substantial multi-year gains may consider trimming exposure to lock in profits, while new entrants might prefer to wait for a more attractive entry point or explore alternative commodity chemical stocks with better valuation metrics.
Conclusion
Grauer & Weil (India) Ltd’s shift from fair to expensive valuation marks a critical juncture for investors. The company’s solid fundamentals and historical outperformance are now tempered by stretched price multiples and a cautious market outlook. The recent downgrade to Sell and the modest short-term price action underscore the need for prudence.
As the commodity chemicals sector continues to evolve, valuation discipline will be key to identifying sustainable investment opportunities. Grauer & Weil’s current standing suggests that while it remains a quality business, its price attractiveness has diminished, warranting a more selective approach from investors.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
